Abstract
The demographical, clinical, and therapeutical features of patients with brucellar spondylodiscitis (BS) were evaluated in this study. Of the 96 patients with brucellosis, 20 (20.8 %) were diagnosed with spondylodiscitis. Patients who had BS were more likely to be older (p = 0.001), have higher erythrocyte sedimentation rates (p = 0.01), and more likely to be anemic (p = 0.017). Lumbar segment (18/20) was frequently involved region. BS was complicated with paravertebral or epidural abscess in seven, radiculitis in six, and psoas abscess in five of cases. Antibiotic regimens including two or three antibiotics with combination of doxycycline, rifampin, and streptomycin were used. In this series, the mean duration of antimicrobial therapy was 18 weeks (range 12–56 weeks). Attention is drawn to this disease given the need for prolonged duration of treatment especially in complicated cases in order to avoid possible sequelae.
References
Calik S, Gokengin D (2011) Human brucellosis in Turkey: a review of the literature between 1990 and 2009. Turk J Med Sci 41:549–555
Doganay M, Aygen B (2003) Human brucellosis: an overview. Int J Infect Dis 7:173–182
Erdem H, Ulu A, Kilic S, Karahocagil M, Sheeta G, Eren-Tulek N, Yetkin F, Celen MK, Ceran N, Gul HC, Mert G, Tekin-Koruk S, Dizbay M, Inal AS, Nayman-Alpat S, Bosilkovski M, Inan D, Saltoglu N, Abdel-Baky L, Adeva-Bartolome MT, Ceylan B, Sacar S, Turhan V, Yilmaz E, Elaldi N, Kocak-Tufan Z, Ugurlu K, Dokuzoguz B, Yilmaz H, Gundes S, Guner R, Ozgunes N, Ulcay A, Unal S, Dayan S, Gorenek L, Karakas A, Tasova Y, Usluer G, Bayindir Y, Kurtaran B, Sipahi OR, Leblebicioglu H (2012) The efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother 56:1523–1528
Gul HC, Erdem H, Bek S (2009) Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis 13:e339–e343
Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005) Brucellosis. N Engl J Med 352:2325–2336
Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H (2010) Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis 14:e469–e478
Abdi-Liae Z, Soudbakhsh A, Jafari S, Tomaj K (2007) Haematological manifestations of brucellosis. Acta Med Iran 45:145–148
Turgut M, Turgut AT, Kosar U (2006) Spinal brucellosis: Turkish experience based on 452 cases published during the last century. Acta Neurochir (Wien) 148:1033–1044 discussion 44
Celik AK, Aypak A, Aypak C (2011) Comparative analysis of tuberculous and brucellar spondylodiscitis. Trop Doct 41:172–174
Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G (2007) Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 4:e317
Colmenero JD, Ruiz-Mesa JD, Plata A, Bermudez P, Martin-Rico P, Queipo-Ortuno MI, Reguera JM (2008) Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin Infect Dis 46:426–433
Pappas G, Seitaridis S, Akritidis N, Tsianos E (2004) Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen. Int J Antimicrob Agents 24:502–507
Alp E, Doganay M (2008) Current therapeutic strategy in spinal brucellosis. Int J Infect Dis 12:573–577
Acknowledgments
The authors would like to thank to Prof. Dr. Mehmet Doganay for his valuable comments and advices.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ulu-Kilic, A., Sayar, M.S., Tütüncü, E. et al. Complicated brucellar spondylodiscitis: experience from an endemic area. Rheumatol Int 33, 2909–2912 (2013). https://doi.org/10.1007/s00296-012-2555-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2555-5